January 08, 2021 1 min read
The U.S. Food and Drug Administration (FDA) has granted BLVK an acceptance letter for its premarket tobacco product application (PMTA).
"As a premium e-liquid brand, we are thrilled to be granted an acceptance letter by the agency and are committed to seeing this process through until our products can be formally and legally marketed in the United States." said BLVK CEO Wilson Sun.
As we always stress, our goal as an electronic cigarette brand is to provide accessibility to legal adult smokers an alternative to combustible tobacco products; and the only way to legally do this is by having the FDA essentially grant us the right to exist on the market.
What Did We Submit for thePMTA?
What Are theNext Steps?
Granted, receiving an acceptance letter from the FDA is simply another notch along the progression line. There is still much to do on the compliance end. We'll continue to work with our compliance partners and the FDA to fully get our submitted products approved over the next 12 to 18 months. Time will tell where we ultimately stand; and we are confident for that final mark of approval.
Sign up to get the latest updates on BLVK.
You must be of legal smoking age to receive our emails.